CERo Therapeutics Holdings, Inc. (CERO)

CERO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.95	3.25	1.52	0.48	1.1
Cash & Short-Term Investments	1.95	3.25	1.52	0.48	1.1
Cash Growth	-42.39%	113.76%	219.73%	-56.68%	-
Prepaid Expenses	0.53	0.27	0.37	0.23	0.26
Restricted Cash	0.07	0.07	0.08	41.67	-
Other Current Assets	-	0.11	-	-	-
Total Current Assets	2.55	3.71	1.97	42.37	1.36
Property, Plant & Equipment	1.18	1.99	3.16	-	-
Long-Term Deferred Tax Assets	-	-	-	-	0.02
Long-Term Deferred Charges	0.17	0.5	-	-	-
Other Long-Term Assets	-	-	-	-	178.7
Total Assets	3.91	6.21	5.13	42.37	180.08
Accounts Payable	7.08	4.51	1.67	1.65	0.01
Accrued Expenses	0.34	1.91	0.14	0	0.08
Short-Term Debt	-	-	0.6	0.65	-
Current Portion of Leases	0.93	0.88	0.77	-	-
Current Income Taxes Payable	-	-	-	0.6	-
Other Current Liabilities	0.11	0.11	0.32	27.84	-
Total Current Liabilities	8.45	7.4	3.51	30.75	0.1
Long-Term Leases	-	0.7	1.58	-	-
Other Long-Term Liabilities	-	-	-	22.62	187.65
Total Liabilities	8.45	8.1	5.08	53.37	187.75
Common Stock	0	0	0	0	0
Additional Paid-In Capital	73.06	67.14	1.03	-	-
Retained Earnings	-86.3	-70.92	-43.09	-11	-7.67
Comprehensive Income & Other	-	-1.3	-	-	-
Total Common Equity	-13.24	-5.07	-42.06	-11	-7.67
Shareholders' Equity	-4.54	-1.89	0.04	-11	-7.67
Total Liabilities & Equity	3.91	6.21	5.13	42.37	180.08
Total Debt	0.93	1.58	2.94	0.65	-
Net Cash (Debt)	1.02	1.68	-1.42	-0.17	1.1
Net Cash Per Share	2.04	65.70	-	-15.48	-
Filing Date Shares Outstanding	21.1	0.27	-	-	0.01
Total Common Shares Outstanding	1.5	0.12	-	-	0.01
Working Capital	-5.9	-3.69	-1.54	11.62	1.26
Book Value Per Share	-8.85	-41.98	-	-	-667.47
Tangible Book Value	-13.24	-5.07	-42.06	-11	-7.67
Tangible Book Value Per Share	-8.85	-41.98	-	-	-667.47
Machinery	2.55	2.55	2.55	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.